TEE
ANGO icon

Tibra Equities Europe’s AngioDynamics ANGO Stock Holding History

Tibra Equities Europe’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-24,500
Closed -$451K – 185
2019
Q3 		$451K Buy
+24,500
New +$479K 0.06% 164
2019
Q2 		– Sell
-10,700
Closed -$245K – 245
2019
Q1 		$245K Buy
+10,700
New +$232K 0.02% 354

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tibra Equities Europe's ANGO Position: Q4 2019 in Review

Tibra Equities Europe sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 24,500 shares — an estimated $451K sold.

Tibra Equities Europe first reported a position in ANGO in Q1 2019 and held it in 2 quarters. The position peaked at $451K in Q3 2019. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

  • Tibra Equities Europe reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 24,500 AngioDynamics shares in Q4 2019, an estimated $451K.
  • Tibra Equities Europe first reported a position in AngioDynamics in Q1 2019 and held it in 2 quarters.
  • Tibra Equities Europe's AngioDynamics position peaked at $451K in Q3 2019.
  • 157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Tibra Equities Europe's 13F filing for Q4 2019, filed 14 Feb 2020.